Business
MDS Receives Notice of Application from PerkinElmer, Inc.
MDS Receives Notice of Application from PerkinElmer, Inc.
About this update from Discovery Harbour Resources Corp.
[{"type":"text","content":"\n\n\n\nDec. 11, 2009 (Canada NewsWire Group) -- TORONTO, Dec. 11 /CNW/ -- MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today announced that it was served with a Notice of Application (the \"Notice\") from PerkinElmer, Inc., with whom MDS has a joint-venture to develop, manufacture and sell inductively coupled plasma mass spectrometers (ICP/MS). This product line represents less than 10% of annual revenue generated by the MDS Analytical Technologies business.In September 2009, MDS agreed to sell its interest in the PerkinElmer joint venture to Danaher Corporation as part of the sale of the MDS Analytical Technologies business, subject to obtaining the consent of PerkinElmer, which is required by the terms of the joint-venture agreement. To date, PerkinElmer has not provided its consent. In the sale agreement, MDS and Danaher agreed that if PerkinElmer's consent was not obtained, MDS would retain its interest in the joint-venture and other related assets, and arrangements would be established to facilitate the continued fulfillment of MDS's joint-venture obligations.The Notice has been filed with the Ontario Superior Court of Justice, and names MDS Inc., Danaher Corporation and DH Technologies Development PTE Ltd. The Notice relates to the sale of MDS Analytical Technologies and seeks a range of alternative possible remedies: court direction with respect to the development of protocols to enforce key provisions of the joint-venture agreement between MDS and PerkinElmer; an injunction preventing enforcement of provisions of the MDS Analytical Technologies/Danaher sale agreement, which provide for MDS's retention of the joint venture; or an interim and permanent injunction preventing the completion of the sale of MDS Analytical Technologies business to Danaher.MDS believes it has a strong position and, if necessary, intends to defend this claim. The Company continues to believe the sale of the MDS Analytical Technologies business will be completed in the first calendar quarter of 2010.MDS does not intend to comment further on these matters unless a material development occurs which requires disclosure.MDS Strategic RepositioningOn September 2, 2009, MDS announced it had reached an agreement to sell its MDS Analytical Technologies business to Danaher Corporation for...